Quanterix Corporation engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; SR-X and SP-X instruments. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.
Market Cap | 750.187 Million | Shares Outstanding | 37.249 Million | Avg 30-day Volume | 422.172 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -2.28 |
Price to Revenue | 4.0284 | Debt to Equity | 0.0 | EBITDA | -87.344 Million |
Price to Book Value | 1.1773 | Operating Margin | -88.998 | Enterprise Value | 91.316 Million |
Current Ratio | 13.958 | EPS Growth | -0.267 | Quick Ratio | 13.064 |
1 Yr BETA | 1.8563 | 52-week High/Low | 23.44 / 6.31 | Profit Margin | -81.0622 |
Operating Cash Flow Growth | 35.008 | Altman Z-Score | 2.7772 | Free Cash Flow to Firm | 2.62 Million |
Earnings Report | 2023-08-08 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
TOLOUE MASOUD PRESIDENT & CEO |
|
292,355 | 2023-04-25 | 9 |
DOYLE MICHAEL A CFO AND TREASURER |
|
88,917 | 2023-04-07 | 11 |
|
264,635 | 2023-04-03 | 5 | |
|
131,236 | 2023-04-03 | 4 | |
|
38,242 | 2023-04-03 | 5 | |
|
0 | 2023-01-06 | 2 | |
|
1,451,519 | 2023-01-03 | 2 | |
|
281,159 | 2023-01-03 | 2 | |
|
27,415 | 2023-01-03 | 1 | |
|
35,582 | 2023-01-03 | 5 | |
FRY JOHN J GENERAL COUNSEL & SECRETARY |
|
37,671 | 2022-08-01 | 2 |
HRUSOVSKY E KEVIN EXECUTIVE CHAIRMAN |
|
910,249 | 2022-07-05 | 1 |
ROSKEY MARK T. SVP, STRATEGIC PARTNERSHIPS |
|
22,325 | 2022-04-01 | 0 |
MATTOON DAWN SR. VP, DIAGNOSTICS |
|
36,876 | 2022-04-01 | 0 |
DUFFY DAVID C. SVP R&D AND CTO |
|
54,730 | 2022-03-23 | 0 |
STETSON SHAWN INTERIM CFO AND TREASURER |
|
8,033 | 2021-05-11 | 0 |
CHAUBAL AMOL CHIEF FINANCIAL OFFICER |
|
30,222 | 2021-05-03 | 0 |
GEIST WILLIAM CHIEF OPERATING OFFICER |
|
56,398 | 2021-02-08 | 0 |
|
11,031 | 2021-01-11 | 0 | |
ARCH VENTURE FUND VIII OVERAGE, L.P. |
|
No longer subject to file | 2020-11-20 | 0 |
|
17,410 | 2020-01-02 | 0 | |
DESJOURDY AMEE CHIEF HUMAN RESOURCE OFFICER |
|
11,834 | 2019-08-19 | 0 |
STREETER JACKSON SVP, CORP DEV & STRATEGY |
|
46,404 | 2019-03-17 | 0 |
DRISCOLL JOSEPH CHIEF FINANCIAL OFFICER |
|
203,773 | 2019-01-15 | 0 |
ORTICERIO ERNEST SVP FINANCE AND CORPORATE DEV |
|
51,585 | 2019-01-09 | 0 |
|
12,440 | 2019-01-02 | 0 | |
BAL BRUCE J VP OF OPS, SERVICE AND QUALITY |
|
5,485 | 2018-05-10 | 0 |
BAIN CAPITAL VENTURE INVESTORS, LLC BAIN CAPITAL VENTURE PARTNERS 2005, L.P. |
|
2,136,085 | 2017-12-11 | 0 |
FLAGSHIP VENTURES FUND 2004 L P |
|
No longer subject to file | 2017-12-11 | 0 |
|
2,055,632 | 2017-12-11 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-02 16:00:42 -0400 | 2023-04-30 | F | 119 | $12.64 | d | 88,917 | direct | 12.1341 | 7.378 | 12.8659 | 3 | 0.0 | 1 | |||
2023-05-02 16:00:44 -0400 | 2023-04-30 | F | 638 | $12.64 | d | 292,355 | direct | 12.1341 | 7.378 | 12.8659 | 3 | 0.0 | 1 | |||
2023-05-02 16:00:44 -0400 | 2023-04-25 | F | 2,683 | $11.67 | d | 292,993 | direct | 12.1341 | 7.378 | 12.8659 | 3 | 0.0 | 1 | |||
2023-05-02 16:00:42 -0400 | 2023-04-07 | F | 1,006 | $12.63 | d | 89,036 | direct | 12.1341 | 7.378 | 12.8659 | 3 | 0.0 | 1 | |||
2023-04-04 16:09:43 -0400 | 2023-04-03 | A | 1,344 | $11.16 | a | 38,242 | direct | 5.8676 | 15.5909 | 51.3831 | 55.1551 | 22 | -2.1794 | 14 | ||
2023-04-04 16:09:23 -0400 | 2023-04-03 | A | 1,344 | $11.16 | a | 264,635 | direct | 5.8676 | 15.5909 | 51.3831 | 55.1551 | 22 | -2.1794 | 14 | ||
2023-04-04 18:23:24 -0400 | 2023-04-03 | A | 1,170 | $11.16 | a | 131,236 | direct | 5.8676 | 15.5909 | 51.3831 | 55.1551 | 22 | -2.1794 | 14 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
QUANTERIX CORP QTRX | 2023-06-01 22:15:04 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 21:45:04 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 21:15:05 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 20:45:03 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 20:15:04 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 19:45:03 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 19:15:04 UTC | 3.7131 | 1.3569 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 18:45:03 UTC | 3.7131 | 1.3569 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 18:15:04 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 17:45:04 UTC | 3.7131 | 1.3569 | 2400000 |
QUANTERIX CORP QTRX | 2023-06-01 17:15:04 UTC | 3.7131 | 1.3569 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 16:45:04 UTC | 3.8734 | 1.1866 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 16:15:04 UTC | 3.8734 | 1.1866 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 15:45:03 UTC | 3.8734 | 1.1866 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 15:15:04 UTC | 3.8734 | 1.1866 | 2300000 |
QUANTERIX CORP QTRX | 2023-06-01 14:45:04 UTC | 3.8734 | 1.1866 | 2300000 |
QUANTERIX CORP QTRX | 2023-06-01 14:15:04 UTC | 3.8734 | 1.1866 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 13:45:04 UTC | 4.089 | 0.971 | 2200000 |
QUANTERIX CORP QTRX | 2023-06-01 13:15:04 UTC | 4.089 | 0.971 | 2300000 |
QUANTERIX CORP QTRX | 2023-06-01 12:45:04 UTC | 4.089 | 0.971 | 2300000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Enhanced Index Plus Fund | QTRX | -20.0 shares, $-367.4 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | QTRX | -11.0 shares, $-202.07 | 2020-03-31 | N-PORT |
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund | QTRX | -3548.0 shares, $-39098.96 | 2022-09-30 | N-PORT |